肥胖创伤与手术患者的静脉血栓栓塞症药物预防方案:系统评价
该系统评价检索7个数据库,纳入45项研究、27717例肥胖创伤或手术患者,评估静脉血栓栓塞症药物预防方案的有效性与安全性。6项研究评估按体重给药方案,4项采用体重分层策略,5项采用体重指数分层方法,29项评估固定剂量方案,2项使用持续输注;多数研究以抗Xa浓度而非静脉血栓栓塞症减少作为主要结局。按体重给药和高固定剂量方案比标准固定剂量方案更常达到目标抗Xa浓度,但未与静脉血栓栓塞症减少相关;高固定剂量方案与出血并发症增加相关。作者认为需要在肥胖创伤和手术患者中开展大型随机试验进一步评估。
要点
- 在肥胖创伤或手术患者中,按体重给药和高固定剂量方案比标准固定剂量方案更常达到目标抗Xa浓度。
- 按体重给药和高固定剂量方案未与静脉血栓栓塞症减少相关。
- 高固定剂量方案与出血并发症增加相关。
- 纳入的45项研究中,29项评估固定剂量方案,仅6项评估按体重给药方案。
- 多数研究以抗Xa浓度而非静脉血栓栓塞症减少作为主要结局。
适用人群与场景
- 肥胖并遭受创伤性损伤的患者。
- 肥胖手术患者。
处置流程与药物剂量
- 按体重给药方案:6项研究评估,比标准固定剂量方案更常达到目标抗Xa浓度,但未与静脉血栓栓塞症减少相关。
- 体重分层或体重分级策略:4项研究采用。
- 体重指数分层方法:5项研究采用。
- 固定剂量方案:29项研究评估,其中高固定剂量方案比标准固定剂量方案更常达到目标抗Xa浓度,但未与静脉血栓栓塞症减少相关,且与出血并发症增加相关。
- 持续输注:2项研究采用。
研究设计与关键结果
- 系统评价共检索到5083条文献,最终纳入45项研究、27717例患者。
- 45项研究中,6项评估按体重给药方案,4项采用体重分层或体重分级策略,5项采用体重指数分层方法,29项评估固定剂量方案,2项使用持续输注。
- 多数研究以抗Xa浓度而非静脉血栓栓塞症减少作为主要结局。
- 按体重给药和高固定剂量方案比标准固定剂量方案更常达到目标抗Xa浓度,但未与静脉血栓栓塞症减少相关。
- 高固定剂量方案与出血并发症增加相关。
证据类型、等级与局限
- 证据类型:系统评价,证据等级III级。
- 偏倚风险评估使用Cochrane偏倚风险评估工具,证据质量采用GRADE工作组标准确定。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,需要在肥胖创伤和手术患者中开展大型随机试验进一步评估静脉血栓栓塞症药物预防方案。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Venous thromboembolism (VTE) continues to be a devastating source of morbidity and mortality in obese patients who suffer traumatic injuries or obese surgery patients. High incidence rates in VTE despite adherence to prevention protocols have stirred interest in new dosing regimens. The purpose of this study was to systematically review the literature and present the existing VTE chemoprophylaxis regimens for obese trauma and surgical patients in terms of efficacy and safety as measured by the incidence of VTE, anti-factor Xa levels, and the occurrence of bleeding events.
METHODS: An online search of seven literature databases including PubMed, Excerpta Medica Database, GoogleScholar, JAMA Network, CINAHL, Cochrane, and SAGE Journals was performed for original studies evaluating the safety and efficacy of VTE chemoprophylaxis dosing regimens according to Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. The risk of bias was assessed using the Cochrane Risk of Bias Tool and the quality of evidence was determined using the GRADE Working Group criteria.
RESULTS: Of the 5,083 citations identified, 45 studies with 27,717 patients met inclusion criteria. In this group, six studies evaluated weight-based dosing regimens, four used a weight-stratified or weight-tiered strategy, five used a body mass index-stratified approach, 29 assessed fixed-dose regimens, and two used continuous infusions. The majority of the studies evaluated anti-factor Xa levels as their primary outcome rather than reduction in VTE.
CONCLUSION: Weight-based and high fixed-dose chemoprophylaxis regimens achieved target anti-Xa concentrations more frequently than standard fixed-dose regimens but were not associated with a reduction in VTE. Additionally, high fixed-dose approaches are associated with increased bleeding complications. Further evaluation with large randomized trials is warranted in trauma and surgery patients with obesity.
LEVEL OF EVIDENCE: Systematic review, level III.
参考来源
- Shaikh S, Boneva D, Hai S, et al. Venous thromboembolism chemoprophylaxis regimens in trauma and surgery patients with obesity: A systematic review. J Trauma Acute Care Surg. 2020. PMID: 31688792. doi:10.1097/TA.0000000000002538
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。